Gene · 10801
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulation of septin cytoskeletal organization in the trabecular meshwork contributes to ocular hypertension. | JCI Insight | 2024 | 39641270 | PubTator, text mining | PubMed |
| Plasma DNA methylation detection for early screening, diagnosis, and monitoring of esophageal adenocarcinoma and squamous cell carcinoma. | World J Gastroenterol | 2024 | 39575407 | PubTator, text mining | PubMed |
| Performance of DNA methylation and blood-borne tumor indicators in detecting colorectal neoplasia and adenomas: a comparative study with the fecal occult blood test. | Front Oncol | 2024 | 39544297 | PubTator, text mining | PubMed |
| The Evidence Base for Circulating Tumor DNA-Methylation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2024 | 39518079 | PubTator, text mining | PubMed |
| A study of the clinical significance of mSEPT9 in monitoring recurrence and prognosis in patients with surgically treated colorectal cancer. | PLoS One | 2024 | 39466813 | PubTator, text mining | PubMed |
| Spectrum of Clinical Variability with SEPT9 Gene Mutation in Hereditary Neuralgic Amyotrophy: Understanding the Pathogenesis Using Molecular Dynamics Simulation Study. | Neurol India | 2024 | 39428775 | PubTator, text mining | PubMed |
| Disrupting CENP-N mediated SEPT9 methylation as a strategy to inhibit aerobic glycolysis and liver metastasis in colorectal cancer. | Clin Exp Metastasis | 2024 | 39424682 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| DNA methylation analysis of the SDC2, SEPT9 and VIM genes in fecal DNA for colorectal cancer diagnosis. | BMC Cancer | 2024 | 39350171 | PubTator, text mining | PubMed |
| SEPT9_i1 and Septin Dynamics in Oncogenesis and Cancer Treatment. | Biomolecules | 2024 | 39334960 | PubTator, text mining | PubMed |
| Predictive nomogram of the clinical outcomes of colorectal cancer based on methylated SEPT9 and intratumoral IL-10+ Tregs infiltration. | J Transl Med | 2024 | 39334238 | PubTator, text mining | PubMed |
| Advances in blood DNA methylation-based assay for colorectal cancer early detection: a systematic updated review. | Gastroenterol Hepatol Bed Bench | 2024 | 39308542 | PubTator, text mining | PubMed |
| Evaluation of Multigene Methylation for Blood-Based Detection of Colorectal Cancer. | Genet Test Mol Biomarkers | 2024 | 39308406 | PubTator, text mining | PubMed |
| The value of SDC2 and Septin9 combined with serum tumor markers in early diagnosis of colorectal cancer. | Int J Colorectal Dis | 2024 | 39289219 | PubTator, text mining | PubMed |
| Engineering with Biomedical Sciences Changing the Horizon of Healthcare-A Review. | Bioengineered | 2024 | 39285709 | PubTator, text mining | PubMed |
| The mechanisms and drug therapies of colorectal cancer and epigenetics: bibliometrics and visualized analysis. | Front Pharmacol | 2024 | 39268463 | PubTator, text mining | PubMed |
| Screening value of methylated Septin9 and lymphocyte-to-monocyte ratio in colorectal cancer. | Medicine (Baltimore) | 2024 | 39259124 | PubTator, text mining | PubMed |
| SEPT9: From pan-cancer to lung squamous cell carcinoma. | BMC Cancer | 2024 | 39237897 | PubTator, text mining | PubMed |
| BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer. | Pharmacol Res | 2024 | 39209080 | PubTator, text mining | PubMed |
| Diagnostic efficacy of SEPT9 and PAX5 gene methylation in gastrointestinal cancer and precancerous lesions. | Cell Mol Biol (Noisy-le-grand) | 2024 | 39097885 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10801/papers?page=8